- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 15.25M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 15.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 15.46M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.84M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.76M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $75.97M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $71.68M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.5B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $736.97M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $624.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $452.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $503.76M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $490.96M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $449.92M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $438.7M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.16B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.25B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.66B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.74B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.78 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.63 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.79 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.65 |
| Net Income | Q1 2026 · Mar 31, 2026 | $12.02M |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.73M |